AU1138097A - Combinations of prostaglandins and miotics for lowering intraocular pressure - Google Patents
Combinations of prostaglandins and miotics for lowering intraocular pressureInfo
- Publication number
- AU1138097A AU1138097A AU11380/97A AU1138097A AU1138097A AU 1138097 A AU1138097 A AU 1138097A AU 11380/97 A AU11380/97 A AU 11380/97A AU 1138097 A AU1138097 A AU 1138097A AU 1138097 A AU1138097 A AU 1138097A
- Authority
- AU
- Australia
- Prior art keywords
- miotics
- prostaglandins
- combinations
- intraocular pressure
- lowering intraocular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57703895A | 1995-12-22 | 1995-12-22 | |
US577038 | 1995-12-22 | ||
PCT/US1996/018888 WO1997023226A1 (en) | 1995-12-22 | 1996-11-25 | Combinations of prostaglandins and miotics for lowering intraocular pressure |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1138097A true AU1138097A (en) | 1997-07-17 |
Family
ID=24307034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11380/97A Abandoned AU1138097A (en) | 1995-12-22 | 1996-11-25 | Combinations of prostaglandins and miotics for lowering intraocular pressure |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1138097A (en) |
WO (1) | WO1997023226A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL350917A1 (en) | 1999-03-05 | 2003-02-10 | Procter & Gamble | C16 unsaturated fp-selective prostaglandins analogs |
US6534541B1 (en) * | 1999-10-19 | 2003-03-18 | Novartis Ag | Treatment of ocular disorders |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2069823T3 (en) * | 1990-05-22 | 1995-05-16 | R Tech Ueno Ltd | TREATMENT OF EYE HYPERTENSION WITH AN EYE SYNERGIC COMBINATION. |
GB9011589D0 (en) * | 1990-05-24 | 1990-07-11 | Wellcome Found | Amino bicyclic compounds |
WO1994005631A1 (en) * | 1992-08-31 | 1994-03-17 | Schering Aktiengesellschaft | 9-chloroprostaglandin esters and amides and their use in the preparation of drugs |
-
1996
- 1996-11-25 AU AU11380/97A patent/AU1138097A/en not_active Abandoned
- 1996-11-25 WO PCT/US1996/018888 patent/WO1997023226A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997023226A1 (en) | 1997-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6584396A (en) | Pressure-actuated valve and method | |
AU5732896A (en) | Prosthetic heart valve | |
AU6529396A (en) | Vascular tissue sealing pressure control and method | |
AU5437396A (en) | Bileaflet heart valve | |
AU5925096A (en) | Low profile holder for heart valve prosthesis | |
AU2221895A (en) | Heart valve prosthesis | |
AU1641295A (en) | Method of making soft tissue products | |
AU3292495A (en) | Integral valve diaphragm pump and method | |
AU4177897A (en) | A tonometer system for measuring intraocular pressure by applanation and/or indentation | |
AU6379796A (en) | Suture protector for prosthetic heart valve | |
AU1725795A (en) | Ep2-receptor agonists as agents for lowering intraocular pressure | |
AU1709699A (en) | 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension | |
AU4502796A (en) | Use of chloride channel blockers for reducing intraocular pressure | |
AU7069696A (en) | Pressure reduction valve | |
AU7680096A (en) | Combinations of dp and fp type prostaglandins for lowering iop | |
AU3832697A (en) | Pressure vessel and method of manufacturing thereof | |
EP0724443A4 (en) | Methods and compositions for lowering intraocular pressure | |
AU7122696A (en) | Minimal contact prosthesis | |
AU4224096A (en) | Use of phenylcyclohexylcarboxamides | |
AU7922291A (en) | Pressure regulating valve | |
AU7318396A (en) | Methods of preserving microorganisms | |
AU1138097A (en) | Combinations of prostaglandins and miotics for lowering intraocular pressure | |
AU6175596A (en) | Methods of modulating nf-kb transcription factor | |
AU5033296A (en) | Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines | |
AU5781496A (en) | Pressure/vacuum valve |